335 related articles for article (PubMed ID: 25868577)
1. Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer.
Yates TJ; Lopez LE; Lokeshwar SD; Ortiz N; Kallifatidis G; Jordan A; Hoye K; Altman N; Lokeshwar VB
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25868577
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.
Lokeshwar VB; Lopez LE; Munoz D; Chi A; Shirodkar SP; Lokeshwar SD; Escudero DO; Dhir N; Altman N
Cancer Res; 2010 Apr; 70(7):2613-23. PubMed ID: 20332231
[TBL] [Abstract][Full Text] [Related]
3. The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activity.
Qin J; Kilkus J; Dawson G
Biochim Biophys Acta; 2016 Feb; 1861(2):78-90. PubMed ID: 26548718
[TBL] [Abstract][Full Text] [Related]
4. Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells.
Benitez A; Yates TJ; Lopez LE; Cerwinka WH; Bakkar A; Lokeshwar VB
Cancer Res; 2011 Jun; 71(12):4085-95. PubMed ID: 21555367
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets.
Morera DS; Hennig MS; Talukder A; Lokeshwar SD; Wang J; Garcia-Roig M; Ortiz N; Yates TJ; Lopez LE; Kallifatidis G; Kramer MW; Jordan AR; Merseburger AS; Manoharan M; Soloway MS; Terris MK; Lokeshwar VB
Br J Cancer; 2017 Nov; 117(10):1507-1517. PubMed ID: 28972965
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.
Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y
Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810
[TBL] [Abstract][Full Text] [Related]
9. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.
Nagase H; Kudo D; Suto A; Yoshida E; Suto S; Negishi M; Kakizaki I; Hakamada K
Pancreas; 2017 Feb; 46(2):190-197. PubMed ID: 27846148
[TBL] [Abstract][Full Text] [Related]
10. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.
Gupta S; Adhami VM; Subbarayan M; MacLennan GT; Lewin JS; Hafeli UO; Fu P; Mukhtar H
Cancer Res; 2004 May; 64(9):3334-43. PubMed ID: 15126378
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.
Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR
Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980
[TBL] [Abstract][Full Text] [Related]
12. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.
Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S
J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions.
Olivares CN; Alaniz LD; Menger MD; Barañao RI; Laschke MW; Meresman GF
PLoS One; 2016; 11(3):e0152302. PubMed ID: 27018976
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer.
Jordan AR; Lokeshwar SD; Lopez LE; Hennig M; Chipollini J; Yates T; Hupe MC; Merseburger AS; Shiedlin A; Cerwinka WH; Liu K; Lokeshwar VB
Oncotarget; 2017 Apr; 8(15):24262-24274. PubMed ID: 27419371
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.
Piccioni F; Malvicini M; Garcia MG; Rodriguez A; Atorrasagasti C; Kippes N; Piedra Buena IT; Rizzo MM; Bayo J; Aquino J; Viola M; Passi A; Alaniz L; Mazzolini G
Glycobiology; 2012 Mar; 22(3):400-10. PubMed ID: 22038477
[TBL] [Abstract][Full Text] [Related]
16. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
Uehara H; Kim SJ; Karashima T; Shepherd DL; Fan D; Tsan R; Killion JJ; Logothetis C; Mathew P; Fidler IJ
J Natl Cancer Inst; 2003 Mar; 95(6):458-70. PubMed ID: 12644539
[TBL] [Abstract][Full Text] [Related]
17. Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype.
El Touny LH; Banerjee PP
Carcinogenesis; 2007 Aug; 28(8):1710-7. PubMed ID: 17468512
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic Acid Inhibitor 4-Methylumbelliferone Activates the Intrinsic Apoptosis Pathway in K562 Chronic Myelogenous Leukemia Cells.
Ban H; Uchakina O; McKallip RJ
Anticancer Res; 2015 Oct; 35(10):5231-40. PubMed ID: 26408682
[TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacodynamics of indole-3-carbinol in the inhibition of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: involvement of Nrf2 and cell cycle/apoptosis signaling pathways.
Wu TY; Saw CL; Khor TO; Pung D; Boyanapalli SS; Kong AN
Mol Carcinog; 2012 Oct; 51(10):761-70. PubMed ID: 21837756
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative "omic" profiling of affected neuroendocrine carcinomas.
Zhang J; Wang L; Zhang Y; Li L; Tang S; Xing C; Kim SH; Jiang C; Lü J
Mol Carcinog; 2015 Dec; 54(12):1567-83. PubMed ID: 25307620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
